As Executive Director of the Institute for Biohealth Innovation, Amy Adams and her team support a talented and innovative research community of faculty and students across multiple disciplines who conduct cutting-edge biomedical and health research. She serves as a point of contact to unite George Mason University (Mason) researchers with the broader community.
Amy’s career at Mason began in 2002. She conducted genomics research using cDNA microarrays and reverse transcription real-time PCR to study mRNA expression in breast cancer and non-alcoholic fatty liver disease. She conducted research and led outreach efforts in the Center for Applied Proteomics and Molecular Medicine from 2005-2007. Amy used laser capture microdissection, western blot, and reverse phase protein microarray technology to investigate phosphorylation events in signaling pathways to discover new rational drug targets and map protein pathways, which could be applied for disease diagnosis and prognosis. In addition to research, Amy led outreach efforts and built programs including the Aspiring Scientists Summer Internship Program and the Galileo’s Science Café to engage high school and undergraduate students in research across STEM disciplines, communicate science to the public, and foster internal and external research collaborations.
Amy earned a M.S. in Chemistry, and a B.S. in Biology, from George Mason University.